Repligen Corporation
RGEN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.84 | -3.48 | 1.15 | 1.09 |
| FCF Yield | 1.77% | 0.75% | 0.41% | 0.33% |
| EV / EBITDA | 97.20 | 78.10 | 37.62 | 67.75 |
| Quality | ||||
| ROIC | -1.22% | 1.09% | 4.69% | 4.96% |
| Gross Margin | 43.29% | 48.84% | 56.85% | 58.35% |
| Cash Conversion Ratio | -6.87 | 2.74 | 0.93 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.50% | -1.93% | 29.83% | 35.38% |
| Free Cash Flow Growth | 90.16% | 93.43% | -18.86% | 31.58% |
| Safety | ||||
| Net Debt / EBITDA | -0.87 | -0.31 | -0.41 | -1.12 |
| Interest Coverage | -1.56 | 4.76 | 44.88 | 10.50 |
| Efficiency | ||||
| Inventory Turnover | 2.52 | 1.60 | 1.45 | 1.51 |
| Cash Conversion Cycle | 189.59 | 277.85 | 275.34 | 257.72 |